David R. Jayne
Hills Road
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Large Vessel Vasculitis Revisited: Mechanistic Insights and Advances in Diagnosis and Management.
Journal: Journal of the American Heart Association
Published: July 28, 2026
ANCA-associated vasculitis and interstitial lung disease: challenges and open questions.
Journal: European journal of internal medicine
Published: July 19, 2025
Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 15, 2025
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.
Journal: Rheumatology (Oxford, England)
Published: December 04, 2024
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.
Journal: BMJ open
Published: July 17, 2024
Efficacy and safety of low- versus high-dose glucocorticoid regimens for induction of remission of anti-neutrophil cytoplasm antibody-associated vasculitis: a systematic review and meta-analysis.
Journal: Scandinavian journal of rheumatology
Published: June 20, 2023
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 17, 2023
Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge.
Journal: Nature immunology
Published: February 14, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial.
Journal: The Lancet. Respiratory medicine
Published: November 21, 2022
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol.
Journal: Trials
Published: October 06, 2022
Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.
Journal: Journal of the American College of Cardiology
Published: August 22, 2022
Last Updated: 09/26/2026